635 related articles for article (PubMed ID: 29175543)
21. Inhibiting RGS1 attenuates secondary inflammation response and tissue degradation via the TLR/TRIF/NF-κB pathway in macrophage post spinal cord injury.
Feng D; Yu J; Bao L; Fan D; Zhang B
Neurosci Lett; 2022 Jan; 768():136374. PubMed ID: 34852285
[TBL] [Abstract][Full Text] [Related]
22. High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.
Ravizza T; Terrone G; Salamone A; Frigerio F; Balosso S; Antoine DJ; Vezzani A
Brain Behav Immun; 2018 Aug; 72():14-21. PubMed ID: 29031614
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of HMGB1 Attenuates Spinal Cord Edema by Reducing the Expression of Na
Li M; Lv J; Wang Z; Wang L; Qin Z; Deng C; Liu J; Sun L
J Neurotrauma; 2023 Dec; 40(23-24):2522-2540. PubMed ID: 36815608
[TBL] [Abstract][Full Text] [Related]
24. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice.
Shechter R; London A; Varol C; Raposo C; Cusimano M; Yovel G; Rolls A; Mack M; Pluchino S; Martino G; Jung S; Schwartz M
PLoS Med; 2009 Jul; 6(7):e1000113. PubMed ID: 19636355
[TBL] [Abstract][Full Text] [Related]
25. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats.
Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Rodriguez Guerrero A; Kobayashi S; Ma WY; Liu SY; Zhu P; Baba H
Spine (Phila Pa 1976); 2011 Dec; 36(25):2122-9. PubMed ID: 21343866
[TBL] [Abstract][Full Text] [Related]
26. HMGB1/Advanced Glycation End Products (RAGE) does not aggravate inflammation but promote endogenous neural stem cells differentiation in spinal cord injury.
Wang H; Mei X; Cao Y; Liu C; Zhao Z; Guo Z; Bi Y; Shen Z; Yuan Y; Guo Y; Song C; Bai L; Wang Y; Yu D
Sci Rep; 2017 Sep; 7(1):10332. PubMed ID: 28871209
[TBL] [Abstract][Full Text] [Related]
27. Astaxanthin ameliorates spinal cord edema and astrocyte activation via suppression of HMGB1/TLR4/NF-κB signaling pathway in a rat model of spinal cord injury.
Abbaszadeh F; Jorjani M; Joghataei MT; Raminfard S; Mehrabi S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3075-3086. PubMed ID: 37145127
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury.
Amo-Aparicio J; Garcia-Garcia J; Francos-Quijorna I; Urpi A; Esteve-Codina A; Gut M; Quintana A; Lopez-Vales R
Theranostics; 2021; 11(20):9805-9820. PubMed ID: 34815787
[No Abstract] [Full Text] [Related]
29. Age decreases macrophage IL-10 expression: Implications for functional recovery and tissue repair in spinal cord injury.
Zhang B; Bailey WM; Braun KJ; Gensel JC
Exp Neurol; 2015 Nov; 273():83-91. PubMed ID: 26263843
[TBL] [Abstract][Full Text] [Related]
30. Programmed death protein 1 is essential for maintaining the anti-inflammatory function of infiltrating regulatory T cells in a murine spinal cord injury model.
He X; Lin S; Yang L; Tan P; Ma P; Qiu P; Zheng C; Zhang X; Kang W; Lin W
J Neuroimmunol; 2021 May; 354():577546. PubMed ID: 33744709
[TBL] [Abstract][Full Text] [Related]
31. Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS.
Lo Coco D; Veglianese P; Allievi E; Bendotti C
Neurosci Lett; 2007 Jan; 412(1):73-7. PubMed ID: 17196331
[TBL] [Abstract][Full Text] [Related]
32. High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury.
Papatheodorou A; Stein A; Bank M; Sison CP; Gibbs K; Davies P; Bloom O
J Neurotrauma; 2017 Feb; 34(3):746-754. PubMed ID: 27673428
[TBL] [Abstract][Full Text] [Related]
33. Higenamine promotes M2 macrophage activation and reduces Hmgb1 production through HO-1 induction in a murine model of spinal cord injury.
Zhang Z; Li M; Wang Y; Wu J; Li J
Int Immunopharmacol; 2014 Dec; 23(2):681-7. PubMed ID: 25445960
[TBL] [Abstract][Full Text] [Related]
34. Prior Treatment with Anti-High Mobility Group Box-1 Antibody Boosts Human Neural Stem Cell Transplantation-Mediated Functional Recovery After Spinal Cord Injury.
Uezono N; Zhu Y; Fujimoto Y; Yasui T; Matsuda T; Nakajo M; Abematsu M; Setoguchi T; Mori S; Takahashi HK; Komiya S; Nishibori M; Nakashima K
Stem Cells; 2018 May; 36(5):737-750. PubMed ID: 29517828
[TBL] [Abstract][Full Text] [Related]
35. CD200 modulates spinal cord injury neuroinflammation and outcome through CD200R1.
Lago N; Pannunzio B; Amo-Aparicio J; López-Vales R; Peluffo H
Brain Behav Immun; 2018 Oct; 73():416-426. PubMed ID: 29870752
[TBL] [Abstract][Full Text] [Related]
36. Transplantation of Human umbilical cord mesenchymal stem cells promotes functional recovery after spinal cord injury by blocking the expression of IL-7.
Bao CS; Li XL; Liu L; Wang B; Yang FB; Chen LG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6436-6447. PubMed ID: 30338812
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of TREM1 reduces inflammation and oxidative stress after spinal cord injury (SCI) associated with HO-1 expressions.
Li Z; Wu F; Xu D; Zhi Z; Xu G
Biomed Pharmacother; 2019 Jan; 109():2014-2021. PubMed ID: 30551457
[TBL] [Abstract][Full Text] [Related]
38. Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway.
Li XQ; Chen FS; Tan WF; Fang B; Zhang ZL; Ma H
J Neuroinflammation; 2017 Oct; 14(1):205. PubMed ID: 29061187
[TBL] [Abstract][Full Text] [Related]
39. Hyperbaric oxygen alleviates experimental (spinal cord) injury by downregulating HMGB1/NF-κB expression.
Yang J; Liu X; Zhou Y; Wang G; Gao C; Su Q
Spine (Phila Pa 1976); 2013 Dec; 38(26):E1641-8. PubMed ID: 24335635
[TBL] [Abstract][Full Text] [Related]
40. Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis.
Agalave NM; Larsson M; Abdelmoaty S; Su J; Baharpoor A; Lundbäck P; Palmblad K; Andersson U; Harris H; Svensson CI
Pain; 2014 Sep; 155(9):1802-1813. PubMed ID: 24954167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
